Evidence map›Paper›PMID 29446117›Full record

ReviewSociology of health & illness2018

The sociology of cancer: a decade of research.

Anne Kerr, Emily Ross, Gwen Jacques, Sarah Cunningham-Burley

Abstract readReview
In one paragraph

Review in Sociology of health & illness, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Experiencing Cancer. An Ethnographic Study on Illness and Disease.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Stable, fragile and recreated - a qualitative study of agency in everyday life with breast and prostate cancer.International journal of qualitative studies on health and well-being · 2019
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anne KerrSchool of Sociology and Social Policy, University of Leeds, UK.
Emily RossThe Usher Institute, Edinburgh Medical School, University of Edinburgh, UK.
Gwen JacquesSchool of Sociology and Social Policy, University of Leeds, UK.
Sarah Cunningham-BurleyThe Usher Institute, Edinburgh Medical School, University of Edinburgh, UK.

Funding

Wellcome TrustWellcome Trust 104831/Z/14/Z
6 · The paper itself

Abstract

Biomedicine is often presented as the driving force behind improvements in cancer care, with genomics the latest innovation poised to change the meaning, diagnosis, treatment, prevention and lived experience of cancer. Reviewing sociological analyses of a diversity of patient and practitioner experiences and accounts of cancer during the last decade (2007-17), we explore the experiences of, approaches to and understandings of cancer in this period. We identify three key areas of focus: (i) cancer patient experiences and identities; (ii) cancer risk and responsibilities and (iii) bioclinical collectives. We explore these sociological studies of societal and biomedical developments and how sociologists have sought to influence developments in cancer identities, care and research. We end by suggesting that we extend our understanding of innovations in the fields of cancer research to take better account of these wider social and cultural innovations, together with patients, activists' and sociologists' contributions therein.

Indexed as

Biomedical ResearchSociology, MedicalCancer SurvivorsGlobal HealthHumansInventionsNeoplasmsRisk Factorsbiomedicinecanceridentityriskscience and technology studies (STS)

Identifiers

PMID29446117
PMCPMC5901049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.